Diagnostics (Jun 2020)

Pathogenic <i>PSEN1</i> Thr119Ile Mutation in Two Korean Patients with Early-Onset Alzheimer’s Disease

  • Eva Bagyinszky,
  • Hyon Lee,
  • Jung Min Pyun,
  • Jeewon Suh,
  • Min Ju Kang,
  • Van Giau Vo,
  • Seong Soo A. An,
  • Kee Hyung Park,
  • SangYun Kim

DOI
https://doi.org/10.3390/diagnostics10060405
Journal volume & issue
Vol. 10, no. 6
p. 405

Abstract

Read online

We report a probable pathogenic Thr119Ile mutation in presenilin-1 (PSEN1) in two unrelated Korean patients, diagnosed with early onset Alzheimer’s disease (EOAD). The first patient presented with memory decline when she was 64 years old. Magnetic resonance imaging (MRI) scans showed diffuse atrophy in the fronto-parietal regions. In addition, 18F-fludeoxyglucose positron emission tomography (FDG-PET) showed reduced tracer uptake in the parietal and temporal cortices, bilaterally. The second patient developed memory dysfunction at the age of 49, and his mother was also affected. Amyloid positron emission tomography (PET) was positive, but MRI scans did not reveal any atrophy. Targeted NGS and Sanger sequencing identified a heterozygous C to T exchange in PSEN1 exon 5 (c.356C>T), resulting in a p.Thr119Ile mutation. The mutation is located in the conserved HL-I loop, where several Alzheimer’s disease (AD) related mutations have been described. Structure analyses suggested that Thr119Ile mutation may result in a significant change inside conservative loop. Additional in vitro studies are needed to estimate the role of the PSEN1 Thr119Ile in AD disease progression.

Keywords